Aprea Therapeutics Inc (NAS:APRE)
$ 0.65 +0.018 (+2.81%) Market Cap: 8.05 Mil Enterprise Value: -38.41 Mil PE Ratio: 0 PB Ratio: 0.19 GF Score: 32/100